Type 2 diabetes trials in Afghanistan

2 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

  Where

  Kabul

  Age

  18 years to 65 years

  People

  2,000 worldwide

  Run by

  Getz Pharma

  See details and how to joinNCT05164263
• No phaseTaking people
  Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

  Where

  Kabul

  Age

  20 years and over

  People

  250

  Run by

  HealthNet Transcultural Psychosocial Organization

  See details and how to joinNCT07350694